Key facts
- It has raised $487.5M; the latest was Debt - Acquisition ($193.6M) in Dec 2024.
- Notable investors include SV Health Investors, Barings, LLR Partners, Benefit Street Partners, Zenyth Partners — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Schweiger Dermatology Group
- ·The full record, as it builds
Funding rounds
No funding rounds for Schweiger Dermatology Group are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Schweiger Dermatology Group
Operator of dermatology and allergy care clinics intended to focus on various skin type diseases and conditions. The company offers treatments for herpes, psoriasis, rosacea, eczema, and acne, enabling patients to get all kinds of skincare needs that might help in achieving their skincare goals.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2010
- Employees
- 1,007
- Website
- schweigerderm.com/
- Ownership
- Privately Held (backing)
Schweiger Dermatology Group doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Schweiger Dermatology Group shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Schweiger Dermatology Group in its N-PORT filings yet. We sweep new filings monthly.